Publication | Open Access

Differential Immune-Related Microenvironment Determines Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Blockade Efficacy in Patients With Advanced NSCLC

InflammationAdvanced NsclcCancer ImmunosurveillanceMedicineApoptosisImmunologyTumor ImmunityCell DeathImmune Checkpoint InhibitorAutoimmunityCellular Immune ResponseImmunotherapyBlockade EfficacyCell BiologyTumor Microenvironment